PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PTC Therapeutics Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Interest Income Expense
-$141.4m
CAGR 3-Years
-18%
CAGR 5-Years
-68%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
10%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$1.1B
CAGR 3-Years
29%
CAGR 5-Years
-12%
CAGR 10-Years
-13%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$3.9B
CAGR 3-Years
-61%
CAGR 5-Years
-41%
CAGR 10-Years
-19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$621.3m
CAGR 3-Years
315%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$697.5m
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is PTC Therapeutics Inc's Interest Income Expense?
Interest Income Expense
-141.4m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Interest Income Expense amounts to -141.4m USD.

What is PTC Therapeutics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-68%

Over the last year, the Interest Income Expense growth was -13%. The average annual Interest Income Expense growth rates for PTC Therapeutics Inc have been -18% over the past three years , -68% over the past five years .

Back to Top